Decesele in septicemii, prevenite prin biotehnologie
0' fill='%23FBBC05' d='M0 37V11l17 13z'/%3e%3cpath clip-path='url(%23b)' fill='%23EA4335' d='M0 11l17 13 7-6.1L48 14V0H0z'/%3e%3cpath clip-path='url(%23b)' fill='%2334A853' d='M0 37l30-23 7.9 1L48 0v48H0z'/%3e%3cpath clip-path='url(%23b)' fill='%234285F4' d='M48 48L17 24l-4-3 35-10z'/%3e%3c/svg%3e){kind=small}
Adaugă-ne ca sursă preferată în Google
' inkscape:export-filename='C:%5cUsers%5cGioSal%5cDesktop%5cGoogle Discover (truT) 326.png' inkscape:export-xdpi='195.8' inkscape:export-ydpi='195.8'%3e %3cdefs id='defs14' /%3e %3csodipodi:namedview pagecolor='white' bordercolor='%23666666' borderopacity='1' objecttolerance='10' gridtolerance='10' guidetolerance='10' inkscape:pageopacity='0' inkscape:pageshadow='2' inkscape:window-width='1920' inkscape:window-height='1057' id='namedview12' showgrid='false' inkscape:zoom='3.280264' inkscape:cx='10.573959' inkscape:cy='124.53611' inkscape:window-x='-8' inkscape:window-y='-8' inkscape:window-maximized='1' inkscape:current-layer='svg10' fit-margin-top='0' fit-margin-left='0' fit-margin-right='0' fit-margin-bottom='0' /%3e %3cmetadata id='metadata2'%3eCreated by potrace 1.15%2c written by Peter Selinger 2001-2017%3crdf:RDF%3e %3ccc:Work rdf:about=''%3e %3cdc:format%3eimage/svg%2bxml%3c/dc:format%3e %3cdc:type rdf:resource='http://purl.org/dc/dcmitype/StillImage' /%3e %3cdc:title%3e%3c/dc:title%3e %3c/cc:Work%3e%3c/rdf:RDF%3e%3c/metadata%3e %3cpath style='fill:%23fbbc01%3bfill-opacity:1%3bstroke:none%3bstroke-width:0.1' inkscape:connector-curvature='0' id='path6' d='m 17.485799%2c17.161672 -7.199999%2c7.3 12.699999%2c12.7 12.8%2c12.8 h -17.8 H 0 v 10 10 h 17.985799 17.8 l 7.2%2c-7.2 7.3%2c-7.2 v -10.1 -10 l -12.8%2c-12.8 -12.7%2c-12.7000001 z' sodipodi:nodetypes='ccccccccccccccccc' /%3e %3cpath style='fill:%23eb4435%3bfill-opacity:1%3bstroke:none%3bstroke-width:0.09999999' inkscape:connector-curvature='0' id='path6-5' d='m 50.05716%2c27.699999 -0.01515%2c27.760627 2.815154%2c-2.760627 c 2.777219%2c-2.723427 2.9%2c-2.7 17.2%2c-2.7 h 14.499999 l 12.7%2c-12.7 L 110.05716%2c24.5 l -7.2%2c-7.2 -7.299997%2c-7.3000001 -12.7%2c12.6999991 -12.799999%2c12.8 v -17.8 V 0 h -10 -10 z' sodipodi:nodetypes='ccsscccccccccccc' /%3e %3cpath style='fill:%234886f4%3bfill-opacity:1%3bstroke:none%3bstroke-width:0.10002016' inkscape:connector-curvature='0' id='path6-2' d='m 52.636899%2c52.666772 c -1.087936%2c1.139283 -3.026919%2c2.966444 -3.435046%2c4.11722 -0.379981%2c1.071417 0.733956%2c1.44349 0.733956%2c3.08278 v 4.5 l 22.709161%2c22.699999 22.809202%2c22.799989 7.202908%2c-7.2 7.30294%2c-7.299989 -12.705122%2c-12.7 -12.805166%2c-12.799999 h 17.807188 17.70714 v -10 -10 H 87.651024 55.337988 Z' sodipodi:nodetypes='csscccccccccccccc' /%3e %3cpath style='fill:%2338a752%3bfill-opacity:1%3bstroke:none%3bstroke-width:0.10003133' inkscape:connector-curvature='0' id='path6-7' d='m 29.872141%2c75.638078 -19.799999%2c19.812414 7.2%2c7.304568 7.3%2c7.20452 12.699999%2c-12.707959 12.8%2c-12.808026 v 17.811155 17.7111 h 10 10 V 102.15469 84.443595 l -10%2c-10.006268 c -9.2%2c-9.105706 -9.778745%2c-10.287283 -10.078745%2c-14.28979 l 0.04861%2c-4.686911 z' sodipodi:nodetypes='cccccccccccccccc' /%3e%3c/svg%3e){kind=small}
Urmărește-ne pe Discover
Agentia Nationala a Medicamentului (ANM) a autorizat in regim de urgenta un produs farmaceutic care va contribui la salvarea vietii bolnavilor de septicemie severa. Sepsisul este o afectiune
Agentia Nationala a Medicamentului (ANM) a autorizat in regim de urgenta un produs farmaceutic care va contribui la salvarea vietii bolnavilor de septicemie severa. Sepsisul este o afectiune determinata de raspunsul inadecvat al organismului la infectii si care duce la moartea a pana la jumatate dintre pacienti. In prezent, in Romania, se inregistreaza anual 8.000-10.000 de cazuri de sepsis sever, iar rata mortalitatii este de 28-50 la suta. Xigris face parte din categoria de medicamente "salvatoare de vieti", fiind eficient in reducerea mortalitatii prin sepsis. Noul medicament reface echilibrul dintre coagulare si fibrinoliza, rupt in septicemiile grave si previne astfel instalarea socului. El se administreaza in paralel cu antibioticele. Xigris (drotrecogin alfa activat) este forma recombinata si activata a proteinei C umane, obtinuta prin biotehnologie. Reprezentantul companiei producatoare a medicamentului a anuntat ca spitalele vor beneficia de Xigris in regim de gratuitate, existand si posibilitatea obtinerii unei finantari separate pentru sepsis, in cadrul unui program national de sanatate. Sepsis-ul face zilnic in lume 1.400 de victime si complica mai multe afectiuni, printre care traumatismele, pneumoniile, leucemia, arsurile si cancerul.
Se încarcă comentariile...
